• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

BioScrip Appoints Tom Ordemann Vice President of Community Pharmacy Operations

Posted on: Friday, 3 August 2007, 12:20 CDT

BioScrip, Inc. (NASDAQ:BIOS), a comprehensive pharmaceutical care solutions company, has named Mr. Tom Ordemann as its Vice President of Community Pharmacy operations. Mr. Ordemann will be responsible for leading the Company's strategic initiatives for the division and ensuring that BioScrip Pharmacy, the Company's community pharmacies, is well positioned to support BioScrip's growth objectives.

Mr. Ordemann was previously employed at Duane Reade, where he had served as Vice President of Operations for the New York Metropolitan region, with responsibility for 250 stores and over 6,500 associates. Prior to Duane Reade, Mr. Ordemann was regional Vice President for Eckerd Drug in the North Florida region, having risen through the ranks from pharmacy department manager to his latest position. In connection with and as an inducement to entering into his employment at BioScrip, Mr. Ordemann was granted 80,000 stock options, which vest in three equal annual installments and 40,000 shares of restricted stock, which vest on January 23, 2008, the six month anniversary of his start date or upon a change in control.

"We are pleased to have Tom Ordemann join our management team. He brings extensive expertise to BioScrip and we will be expecting a lot of great things from him." noted Mr. Richard H. Friedman, the Company's Chairman and Chief Executive Officer.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (NASDAQ: BIOS) is a specialty pharmaceutical health care organization that partners with patients, physicians, health care payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, the Company's ability to continue improving the above identified trends and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

Source: Business Wire

More News in this Category